Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 11:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2425–2448 of 8,279 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Dizziness, Brain Injury
Interventions: Not listed
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Mountain Home, Tennessee

Conditions: Bone Loss, Aging
Interventions: placebo, denosumab; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 25 Years to 80 Years · Female only
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Single-ventricle, Infant Conditions, Infant, Newborn, Diseases, Infant, Premature, Diseases
Interventions: PK/PD Model Based Dosing of Digoxin in Infants with Single Ventricle Heart Disease; Drug
Lead sponsor: Duke University; Other
Eligibility: 30 Days to 6 Months
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Durham, North Carolina • Charleston, South Carolina

Conditions: Brain Injuries, Traumatic
Interventions: Standard Overground Assessment, Robotic Safety-Environment Assessment; Diagnostic Test
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Atopic Dermatitis
Interventions: Tilrekimig, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 12 Years and older
Enrollment: 375 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 15
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Bakersfield, California + 12 more

Conditions: Dental Implants, TNF-alpha Inhibitors, Edentulism
Interventions: Placement of dental implants; Procedure
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Safety and Tolerability of Iloperidone
Interventions: iloperidone (oral tablet); Drug
Lead sponsor: Vanda Pharmaceuticals; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 10
States / cities: Costa Mesa, California • North Miami, Florida • Atlanta, Georgia + 7 more

Conditions: Acute Myeloid Leukemia, Blasts 20 Percent or More of Bone Marrow Nucleated Cells, High Risk Myelodysplastic Syndrome, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent High Risk Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia, Refractory High Risk Myelodysplastic Syndrome
Interventions: Cladribine, Cytarabine, Idarubicin, Quizartinib; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Tetanus, Acellular Pertussis, Diphtheria
Interventions: SB213503 lot 1, SB213503 lot 2, SB213503 lot 3, Infanrix, IPOL, M-M-R II; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 4 Years to 6 Years
Enrollment: 4,209 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 24
States / cities: Little Rock, Arkansas • Antioch, California • Daly City, California + 20 more

Conditions: Cancer
Interventions: Not listed
Lead sponsor: University of Vermont; Other
Eligibility: 65 Years to 90 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Dengue
Interventions: TetraVax-DV TV005, Placebo; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 50 Years to 70 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Nonalcoholic Steatohepatitis, Nonalcoholic Fatty Liver
Interventions: Ultrasound based shear wave speed and fat quantification methods, Blood collection, Physical measurements, Clinical history and medication reviews; Device · Diagnostic Test · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 2
States / cities: San Diego, California • Boston, Massachusetts

Conditions: Multiple Chronic Illnesses
Interventions: Not listed
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: Not listed
Enrollment: 241,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Kidney Transplant; Complications, Toxicity, Drug Toxicity, Neurotoxicity
Interventions: Envarsus, IR Tacrolimus; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 60 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Diet, Healthy, Health Behavior, Blood Pressure, Diabetes Mellitus Risk, Utilization, Health Care
Interventions: PhytoRx Families: A Pilot Test to Address Food Security in Rural North Carolina; Other
Lead sponsor: North Carolina State University; Other
Eligibility: 8 Years to 64 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Raleigh, North Carolina

Conditions: Autism Spectrum Disorder, Depressive Disorder, Anxiety Disorders
Interventions: CBT-DAY (Cognitive Behavioral Therapy for Depression in Autistic Youth), Treatment-as-Usual (TAU); Behavioral
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 11 Years to 17 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Dravet Syndrome
Interventions: ION337; Drug
Lead sponsor: Ionis Pharmaceuticals, Inc.; Industry
Eligibility: 2 Years to 12 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 6
States / cities: Ann Arbor, Michigan • Rochester, Minnesota • Durham, North Carolina + 3 more

Conditions: Diabetes
Interventions: Not listed
Lead sponsor: Eastern Virginia Medical School; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Age Related Macular Degeneration, Macular Degeneration, AMD
Interventions: HuCNS-SC cells; Drug
Lead sponsor: StemCells, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 5
States / cities: Los Angeles, California • Palo Alto, California • New York, New York + 2 more

Conditions: Autism Spectrum Disorders
Interventions: Vasopressin, Placebo; Drug
Lead sponsor: Stanford University; Other
Eligibility: 6 Years to 12 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Cough
Interventions: Label; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 312 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Neural Tube Defects, Folic Acid Deficiency, Spina Bifida, Anencephaly-Spina Bifida
Interventions: Folic acid fortified iodized salt; Dietary Supplement
Lead sponsor: Hydrocephalus and Neuroscience Institute; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Healthy
Interventions: ENGN Shred, Nutricost caffeine powder, Crystal Light; Dietary Supplement
Lead sponsor: Northern Illinois University; Other
Eligibility: 19 Years to 29 Years · Male only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: DeKalb, Illinois

Conditions: Alcohol Consumption, Drug-Food Interaction
Interventions: Online alcohol educational class; Behavioral
Lead sponsor: Arlene Fink Associates; Industry
Eligibility: 55 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Pacific Palisades, California

Search by objective public record fields.

Vestibular Consequences of Blast-related Mild Traumatic Brain Injury (TBI)

Osteoclast Inhibition and Bone Formation

PK/PD of Digoxin in Infants With SVHD

Estimating Highest Capacity Performance During Evaluation of Walking for Individuals With Traumatic Brain Injury

A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

Dental Implant Healing With TNF-Alpha Inhibitors

Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients

Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

Outcomes of Oncology Therapy in the Elderly: Trajectory of Functional Decline and Correlates of Change

Evaluating the Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TetraVax-DV) TV005 in Flavivirus-Naive Adults 50 to 70 Years of Age

Noninvasive Biomarkers of Metabolic Liver Disease 1.1

Assessing Costs & Cost-variability Among Enrollees of Health Insurance Programs Utilizing Charlson's Comorbidity Index and Administrative Databases

Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients

A Food As Medicine Approach to Address Food Insecurity in Rural North Carolina

Feasibility, Acceptability, and Preliminary Effectiveness of Cognitive Behavioral Therapy for Depression in Autistic Youth in Clinical Settings

ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

Ultrasound Findings in Diabetic Pregnancies

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)

The Role of Vasopressin in the Social Deficits of Autism

Promoting Safe Use of Children's Cough/Cold Medicines

Salt-FA to Increase Folate Levels

Pre-workout Supplement Versus Caffeine on Energy Expenditure.

Online Education to Inform the Elderly About Age-related Alcohol Risks